Shed Expands GLP-1 Weight-Loss Offerings with Wegovy® Pills via NovoCare

SALT LAKE CITY, Jan. 14, 2026 /PRNewswire/ — Shed, a leading health and wellness platform focused on accessible, clinician-guided care, today announced the expansion of its GLP-1 weight-loss programs with the introduction of Wegovy® pills via NovoCare. This new offering provides members…

Is It Time to Dump Your Shares of Eli Lilly?

Key Points Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has now introduced a pill version of its GLP-1 weight loss drug. Eli Lilly’s valuation looks stretched at this point — both against the industry and overall market. 10 stocks we like better than […]

Is It Time to Dump Your Shares of Eli Lilly?

If you bought Eli Lilly (NYSE: LLY) shares five years ago, you are sitting on some massive gains. The stock is up over 470% compared to a gain of roughly 85% for the S&P 500 index and a roughly 4% advance for the average pharmaceutical stock. Should you hold on to a big winner like […]

Stopping GLP-1s May Lead to Weight Regain In Less Than 2 Years, Review Finds

Research shows that people who stop taking GLP-1 medications regain weight within 2 years. Image Credit: Tatsiana Volkava/Getty Images A new study has found that people regain weight within 2 years of stopping a GLP-1 drug. Metabolic improvements also tend to fade within that time, researchers found. Experts advise that slowly tapering off the medication […]